A registry-based cohort study of pulmonary tuberculosis treatment outcomes in Istanbul, Turkey.
A registry-based cohort study of pulmonary tuberculosis treatment outcomes in Istanbul, Turkey.
Jpn J Infect Dis. 2013;66(2):115-20
Authors: Babalik A, Kilicaslan Z, Caner SS, Gungor G, Ortakoylu MG, Gencer S, McCurdy SA
Abstract
The aim of this study is to evaluate the treatment outcomes and identify factors associated with adverse tuberculosis treatment outcomes for bacteriologically confirmed pulmonary tuberculosis. Treatment outcomes of pulmonary tuberculosis were evaluated retrospectively among 11,186 smear- and/or culture-positive patients treated between 2006 and 2009 in Istanbul, Turkey. Adverse treatment outcomes were identified in 1,010 (9.0%) patients including death (1.8%), treatment default (6.1%), and treatment failure (1.1%). Factors associated with adverse treatment outcomes included being born abroad (odds ratios [OR], 5.38; 95% confidence intervals [CI], 3.67-7.91), history of tuberculosis treatment (OR, 3.77; 95% CI, 3.26-4.36), age > 65 years (OR, 2.79; 95% CI, 2.21-3.53), and male gender (OR, 1.91; 95% CI, 1.59-2.27). Death was most strongly associated with age > 65 years (OR, 45.1; 95% CI, 27.0-75.6), followed by treatment default with history of interrupted treatment (OR, 11.6; 95% CI, 8.94-15.1), and treatment failure with prior history of treatment failure (OR, 17.1; 95% CI, 6.97-41.6). Multidrug resistance was strongly associated with adverse treatment outcomes (OR, 10.8; 95% CI, 8.02-14.6). Age > 65 years, m...
Source: Japanese Journal of Infectious Diseases - Category: Infectious Diseases Authors: Babalik A, Kilicaslan Z, Caner SS, Gungor G, Ortakoylu MG, Gencer S, McCurdy SA Tags: Jpn J Infect Dis Source Type: research
More News: Infectious Diseases | Middle East Health | Multidrug Resistance | Papanicolaou (Pap) Smear | Study | Tuberculosis